{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:26:06Z","timestamp":1760145966710,"version":"build-2065373602"},"reference-count":32,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T00:00:00Z","timestamp":1727049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biology"],"abstract":"<jats:p>This study explored the potential causal relationship between ibuprofen (IBU) use and the risk of developing osteoarthritis, a prevalent joint disorder characterized by pain and stiffness. We conducted a two-sample MR analysis using four distinct OA GWAS datasets as outcomes and single-nucleotide polymorphisms (SNPs) associated with IBU metabolism as exposures. The inverse variance weighted (IVW) and weighted median methods were utilized to assess the causal association by meta-analysis, while pleiotropy and heterogeneity were evaluated using MR\u2013Egger regression and Cochran\u2019s Q statistics. The MR analysis provided strong evidence for a causal association between IBU use and an increased risk of OA. A meta-analysis of the IVW and weighted median results across all datasets demonstrated an OR = 1.116 (95% CI = 1.063\u20131.170) and an OR = 1.110 (95% CI = 1.041\u20131.184). The consistency of the results obtained from different methods enhanced the reliability of the findings. Low pleiotropy and minimal heterogeneity were observed, further validating the results. The study supports a causal link between IBU use and an increased risk of OA, suggesting that IBU may accelerate the progression of OA while relieving symptoms. These findings highlight the importance of cautious use of IBU in clinical practice, especially considering its potential impact on long-term joint health.<\/jats:p>","DOI":"10.3390\/biology13090748","type":"journal-article","created":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T08:56:06Z","timestamp":1727168166000},"page":"748","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exploring the Causal Relationship between Ibuprofen Use and Osteoarthritis Risk: A Mendelian Randomization Study"],"prefix":"10.3390","volume":"13","author":[{"given":"Yongzhi","family":"Jian","sequence":"first","affiliation":[{"name":"Institute of Biochemistry, Medical Faculty, Friedrich-Alexander-University of Erlangen-N\u00fcrnberg, 91054 Erlangen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1370-256X","authenticated-orcid":false,"given":"Yanmin","family":"Lyu","sequence":"additional","affiliation":[{"name":"Division of Molecular and Experimental Surgery, Translational Research Center, Universit\u00e4tsklinikum Erlangen, Friedrich-Alexander-University of Erlangen-N\u00fcrnberg, 91054 Erlangen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6564-5649","authenticated-orcid":false,"given":"Said","family":"Hashemolhosseini","sequence":"additional","affiliation":[{"name":"Institute of Biochemistry, Medical Faculty, Friedrich-Alexander-University of Erlangen-N\u00fcrnberg, 91054 Erlangen, Germany"},{"name":"Muscle Research Center, Friedrich-Alexander-University of Erlangen-N\u00fcrnberg, 91054 Erlangen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,9,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"635","DOI":"10.7326\/0003-4819-133-8-200010170-00016","article-title":"Osteoarthritis: New Insights. Part 1: The Disease and Its Risk Factors","volume":"133","author":"Felson","year":"2000","journal-title":"Ann. Intern. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"16072","DOI":"10.1038\/nrdp.2016.72","article-title":"Osteoarthritis","volume":"2","author":"Barr","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.2147\/IJGM.S314180","article-title":"The Causal Relationship Between Body Mass Index and the Risk of Osteoarthritis","volume":"14","author":"He","year":"2021","journal-title":"Int. J. Gen. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1136\/bjsports-2022-105496","article-title":"Risk Factors for Knee Osteoarthritis after Traumatic Knee Injury: A Systematic Review and Meta-Analysis of Randomised Controlled Trials and Cohort Studies for the OPTIKNEE Consensus","volume":"56","author":"Whittaker","year":"2022","journal-title":"Br. J. Sports Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0140-6736(14)60802-3","article-title":"Osteoarthritis","volume":"386","author":"Palmer","year":"2015","journal-title":"Lancet"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/acr.21596","article-title":"American College of Rheumatology 2012 Recommendations for the Use of Nonpharmacologic and Pharmacologic Therapies in Osteoarthritis of the Hand, Hip, and Knee","volume":"64","author":"Hochberg","year":"2012","journal-title":"Arthritis Care Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.tips.2017.05.008","article-title":"The Cardiovascular Pharmacology of Nonsteroidal Anti-Inflammatory Drugs","volume":"38","author":"Grosser","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_8","first-page":"1247","article-title":"Gastrointestinal Toxicity With Celecoxib Vs","volume":"284","author":"Silvernstein","year":"2000","journal-title":"J. Am. Med. Assoc."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0140-6736(13)60900-9","article-title":"Vascular and Upper Gastrointestinal Effects of Non-Steroidal Anti-Inflammatory Drugs: Meta-Analyses of Individual Participant Data from Randomised Trials","volume":"382","author":"Baigent","year":"2013","journal-title":"Lancet"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"j1909","DOI":"10.1136\/bmj.j1909","article-title":"Risk of Acute Myocardial Infarction with NSAIDs in Real World Use: Bayesian Meta-Analysis of Individual Patient Data","volume":"357","author":"Bally","year":"2017","journal-title":"Br. Med. J."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/S0140-6736(11)60243-2","article-title":"Osteoarthritis: An Update with Relevance for Clinical Practice","volume":"377","author":"Bijlsma","year":"2011","journal-title":"Lancet"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ije\/dyg070","article-title":"\u2018Mendelian Randomization\u2019: Can Genetic Epidemiology Contribute to Understanding Environmental Determinants of Disease?*","volume":"32","author":"Ebrahim","year":"2003","journal-title":"Int. J. Epidemiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1093\/ije\/dyx028","article-title":"Two-Sample Mendelian Randomization: Avoiding the Downsides of a Powerful, Widely Applicable but Potentially Fallible Technique","volume":"45","author":"Hartwig","year":"2016","journal-title":"Int. J. Epidemiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1093\/aje\/kwt084","article-title":"Efficient Design for Mendelian Randomization Studies: Subsample and 2-Sample Instrumental Variable Estimators","volume":"178","author":"Pierce","year":"2013","journal-title":"Am. J. Epidemiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/gepi.21758","article-title":"Mendelian Randomization Analysis With Multiple Genetic Variants Using Summarized Data","volume":"37","author":"Burgess","year":"2013","journal-title":"Genet. Epidemiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/ije\/dyr036","article-title":"Avoiding Bias from Weak Instruments in Mendelian Randomization Studies","volume":"40","author":"Burgess","year":"2011","journal-title":"Int. J. Epidemiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian Randomization with Invalid Instruments: Effect Estimation and Bias Detection through Egger Regression","volume":"44","author":"Bowden","year":"2015","journal-title":"Int. J. Epidemiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/gepi.21965","article-title":"Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator","volume":"40","author":"Bowden","year":"2016","journal-title":"Genet. Epidemiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1093\/ije\/dyx102","article-title":"Robust Inference in Summary Data Mendelian Randomization via the Zero Modal Pleiotropy Assumption","volume":"46","author":"Hartwig","year":"2017","journal-title":"Int. J. Epidemiol."},{"key":"ref_20","first-page":"1961","article-title":"Assessing the Suitability of Summary Data for Two-Sample Mendelian Randomization Analyses Using MR-Egger Regression: The Role of the I2 Statistic","volume":"45","author":"Bowden","year":"2016","journal-title":"Int. J. Epidemiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying Heterogeneity in a Meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring Inconsistency in Meta-Analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"Br. Med. J."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1023\/A:1015504632021","article-title":"Do NSAIDs Affect the Progression of Osteoarthritis?","volume":"26","author":"Ding","year":"2002","journal-title":"Inflammation"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1177\/1759720X16664323","article-title":"Exploratory Analysis of Osteoarthritis Progression among Medication Users: Data from the Osteoarthritis Initiative","volume":"8","author":"Driban","year":"2016","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"4624","DOI":"10.1093\/rheumatology\/keab059","article-title":"Association between Current Medication Use and Progression of Radiographic Knee Osteoarthritis: Data from the Osteoarthritis Initiative","volume":"60","author":"Perry","year":"2021","journal-title":"Rheumatology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"R89","DOI":"10.1093\/hmg\/ddu328","article-title":"Mendelian Randomization: Genetic Anchors for Causal Inference in Epidemiological Studies","volume":"23","author":"Hemani","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.amjmed.2005.09.054","article-title":"Celecoxib Versus Naproxen and Diclofenac in Osteoarthritis Patients: SUCCESS-I Study","volume":"119","author":"Singh","year":"2006","journal-title":"Am. J. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s10787-009-0016-x","article-title":"Ibuprofen: Pharmacology, Efficacy and Safety","volume":"17","author":"Rainsford","year":"2009","journal-title":"Inflammopharmacology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.amjmed.2009.03.022","article-title":"Do NSAIDs Affect Longitudinal Changes in Knee Cartilage Volume and Knee Cartilage Defects in Older Adults?","volume":"122","author":"Ding","year":"2009","journal-title":"Am. J. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1002\/art.21357","article-title":"Is There an Association between the Use of Different Types of Nonsteroidal Antiinflammatory Drugs and Radiologic Progression of Osteoarthritis?: The Rotterdam Study","volume":"52","author":"Reijman","year":"2005","journal-title":"Arthritis Rheum."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0140-6736(98)12154-2","article-title":"New Drug Classes COX-2 Inhibitors","volume":"353","author":"Hawkey","year":"1999","journal-title":"Lancet"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1177\/0363546514533777","article-title":"Chondroprotection and the Prevention of Osteoarthritis Progression of the Knee","volume":"43","author":"Gallagher","year":"2015","journal-title":"Am. J. Sports Med."}],"container-title":["Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-7737\/13\/9\/748\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:02:53Z","timestamp":1760112173000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-7737\/13\/9\/748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,23]]},"references-count":32,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["biology13090748"],"URL":"https:\/\/doi.org\/10.3390\/biology13090748","relation":{},"ISSN":["2079-7737"],"issn-type":[{"type":"electronic","value":"2079-7737"}],"subject":[],"published":{"date-parts":[[2024,9,23]]}}}